172 related articles for article (PubMed ID: 17225121)
21. Predictive effects of urinary liver-type fatty acid-binding protein for deteriorating renal function and incidence of cardiovascular disease in type 2 diabetic patients without advanced nephropathy.
Araki S; Haneda M; Koya D; Sugaya T; Isshiki K; Kume S; Kashiwagi A; Uzu T; Maegawa H
Diabetes Care; 2013 May; 36(5):1248-53. PubMed ID: 23223350
[TBL] [Abstract][Full Text] [Related]
22. Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes.
Dalla Vestra M; Mussap M; Gallina P; Bruseghin M; Cernigoi AM; Saller A; Plebani M; Fioretto P
J Am Soc Nephrol; 2005 Mar; 16 Suppl 1():S78-82. PubMed ID: 15938041
[TBL] [Abstract][Full Text] [Related]
23. Increased levels of mannan-binding lectin in type 1 diabetic patients with incipient and overt nephropathy.
Saraheimo M; Forsblom C; Hansen TK; Teppo AM; Fagerudd J; Pettersson-Fernholm K; Thiel S; Tarnow L; Ebeling P; Flyvbjerg A; Groop PH;
Diabetologia; 2005 Jan; 48(1):198-202. PubMed ID: 15616805
[TBL] [Abstract][Full Text] [Related]
24. C-Terminal Fragment of Agrin (CAF): A Novel Marker for Progression of Kidney Disease in Type 2 Diabetics.
Devetzis V; Daryadel A; Roumeliotis S; Theodoridis M; Wagner CA; Hettwer S; Huynh-Do U; Ploumis P; Arampatzis S
PLoS One; 2015; 10(12):e0143524. PubMed ID: 26630274
[TBL] [Abstract][Full Text] [Related]
25. Plasma N-terminal pro-brain natriuretic peptide as an independent predictor of mortality in diabetic nephropathy.
Tarnow L; Hildebrandt P; Hansen BV; Borch-Johnsen K; Parving HH
Diabetologia; 2005 Jan; 48(1):149-55. PubMed ID: 15616804
[TBL] [Abstract][Full Text] [Related]
26. Plasma N-terminal pro-B-type natriuretic peptide and mortality in type 2 diabetes.
Tarnow L; Gall MA; Hansen BV; Hovind P; Parving HH
Diabetologia; 2006 Oct; 49(10):2256-62. PubMed ID: 16937127
[TBL] [Abstract][Full Text] [Related]
27. [Cytokines in noninvasive diagnostics of diabetic nephropathy progression].
Senatorski G; Paczek L; Kropiewnicka E; Bartłomiejczyk I
Pol Merkur Lekarski; 2002 Nov; 13 Suppl 1():28-32. PubMed ID: 12621778
[TBL] [Abstract][Full Text] [Related]
28. Measurement of the intrarenal arterial resistance index for the identification and prediction of diabetic nephropathy.
Masulli M; Mancini M; Liuzzi R; Daniele S; Mainenti PP; Vergara E; Genovese S; Salvatore M; Vaccaro O
Nutr Metab Cardiovasc Dis; 2009 Jun; 19(5):358-64. PubMed ID: 18805683
[TBL] [Abstract][Full Text] [Related]
29. Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria.
Gaede P; Tarnow L; Vedel P; Parving HH; Pedersen O
Nephrol Dial Transplant; 2004 Nov; 19(11):2784-8. PubMed ID: 15328385
[TBL] [Abstract][Full Text] [Related]
30. Changes in the inflammatory markers with advancing stages of diabetic nephropathy and the role of pentraxin-3.
Uzun S; Ozari M; Gursu M; Karadag S; Behlul A; Sari S; Koldas M; Demir S; Karaali Z; Ozturk S
Ren Fail; 2016 Sep; 38(8):1193-8. PubMed ID: 27436699
[TBL] [Abstract][Full Text] [Related]
31. Association of low-grade inflammation with nephropathy in type 2 diabetic patients: role of elevated CRP-levels and 2 different gene-polymorphisms of proinflammatory cytokines.
Abrahamian H; Endler G; Exner M; Mauler H; Raith M; Endler L; Rumpold H; Gerdov M; Mannhalter C; Prager R; Irsigler K; Wagner OF
Exp Clin Endocrinol Diabetes; 2007 Jan; 115(1):38-41. PubMed ID: 17286233
[TBL] [Abstract][Full Text] [Related]
32. The influence of sex on renal function decline in people with Type 2 diabetes.
de Hauteclocque A; Ragot S; Slaoui Y; Gand E; Miot A; Sosner P; Halimi JM; Zaoui P; Rigalleau V; Roussel R; Saulnier PJ; Hadjadj Samy S;
Diabet Med; 2014 Sep; 31(9):1121-8. PubMed ID: 24773061
[TBL] [Abstract][Full Text] [Related]
33. Systemic and vascular inflammation is elevated in early IgA and type 1 diabetic nephropathies and relates to vascular disease risk factors and renal function.
Nelson CL; Karschimkus CS; Dragicevic G; Packham DK; Wilson AM; O'Neal D; Becker GJ; Best JD; Jenkins AJ
Nephrol Dial Transplant; 2005 Nov; 20(11):2420-6. PubMed ID: 16115854
[TBL] [Abstract][Full Text] [Related]
34. [Microalbuminuria and diabetic nephropathy. Detection and correlation with other degenerative complications].
Thivolet C; Ayzac L; Simonet C; Rebattu B; Bernard P; Tourniaire J
Presse Med; 1990 Jun; 19(23):1075-80. PubMed ID: 2141408
[TBL] [Abstract][Full Text] [Related]
35. Silent cerebral infarction is associated with the development and progression of nephropathy in patients with type 2 diabetes.
Bouchi R; Babazono T; Yoshida N; Nyumura I; Toya K; Hayashi T; Hanai K; Tanaka N; Ishii A; Iwamoto Y
Hypertens Res; 2010 Oct; 33(10):1000-3. PubMed ID: 20613763
[TBL] [Abstract][Full Text] [Related]
36. [An association between adiponectin and renal dysfunction in patients with type 2 diabetes mellitus].
Galovičová A; Lazúrová I; Petrášová D
Vnitr Lek; 2012 Nov; 58(11):825-9. PubMed ID: 23256827
[TBL] [Abstract][Full Text] [Related]
37. Relationships among microalbuminuria, insulin resistance and renal-cardiac complications in insulin dependent and non insulin dependent diabetes.
Nosadini R; Brocco E
Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():1-7. PubMed ID: 9288531
[TBL] [Abstract][Full Text] [Related]
38. High frequencies of diabetic micro- and macroangiopathies in patients with type 2 diabetes mellitus with decreased estimated glomerular filtration rate and normoalbuminuria.
Ito H; Takeuchi Y; Ishida H; Antoku S; Abe M; Mifune M; Togane M
Nephrol Dial Transplant; 2010 Apr; 25(4):1161-7. PubMed ID: 19892756
[TBL] [Abstract][Full Text] [Related]
39. Association between urinary type IV collagen level and deterioration of renal function in type 2 diabetic patients without overt proteinuria.
Araki S; Haneda M; Koya D; Isshiki K; Kume S; Sugimoto T; Kawai H; Nishio Y; Kashiwagi A; Uzu T; Maegawa H
Diabetes Care; 2010 Aug; 33(8):1805-10. PubMed ID: 20668153
[TBL] [Abstract][Full Text] [Related]
40. The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension.
Busch M; Franke S; Wolf G; Brandstädt A; Ott U; Gerth J; Hunsicker LG; Stein G;
Am J Kidney Dis; 2006 Oct; 48(4):571-9. PubMed ID: 16997053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
